Nanomedicine

metrics 2024

Unlocking New Frontiers in Biomedical Engineering

Introduction

Nanomedicine, published by Future Medicine Ltd, is a premier academic journal dedicated to the rapidly evolving field of nanotechnology in medicine. With an emphasis on innovative research and applications, this journal encompasses a broad spectrum of topics including bioengineering, biomedical engineering, and nanoscience, among others. Featuring an impressive Q1 ranking in Development and multiple Q2 rankings across significant categories, it serves as a pivotal resource for researchers and professionals aiming to stay at the forefront of advancements in these disciplines. While the journal is not open access, it is accessible through various institutional subscriptions, ensuring wide dissemination of cutting-edge findings. Notably, it has achieved substantial impact within the scientific community, indicated by its high rankings in Scopus and overall commitment to enhancing the understanding and application of nanomedicine. This journal is a vital conduit for fostering collaborations and innovations that transcend traditional medical paradigms.

Metrics 2024

SCIMAGO Journal Rank0.67
Journal Impact Factor4.70
Journal Impact Factor (5 years)5.10
H-Index135
Journal IF Without Self4.70
Eigen Factor0.00
Normal Eigen Factor0.99
Influence0.73
Immediacy Index1.00
Cited Half Life7.10
Citing Half Life6.00
JCI0.67
Total Documents2960
WOS Total Citations9839
SCIMAGO Total Citations37324
SCIMAGO SELF Citations1627
Scopus Journal Rank0.67
Cites / Document (2 Years)3.54
Cites / Document (3 Years)4.05
Cites / Document (4 Years)4.40

Metrics History

Rank 2024

Scopus

Development in Social Sciences
Rank #26/306
Percentile 91.50
Quartile Q1
Medicine (miscellaneous) in Medicine
Rank #51/398
Percentile 87.19
Quartile Q1
General Materials Science in Materials Science
Rank #99/463
Percentile 78.62
Quartile Q1
Biomedical Engineering in Engineering
Rank #66/303
Percentile 78.22
Quartile Q1
Bioengineering in Chemical Engineering
Rank #44/162
Percentile 72.84
Quartile Q2

IF (Web Of Science)

BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Rank 29/174
Percentile 83.60
Quartile Q1
NANOSCIENCE & NANOTECHNOLOGY
Rank 55/140
Percentile 61.10
Quartile Q2

JCI (Web Of Science)

BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Rank 82/174
Percentile 52.87
Quartile Q2
NANOSCIENCE & NANOTECHNOLOGY
Rank 64/140
Percentile 54.29
Quartile Q2

Quartile History

Similar Journals

Current Drug Delivery

Catalyzing advancements in drug delivery systems.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1567-2018Frequency: 10 issues/year

Current Drug Delivery, published by Bentham Science Publishers Ltd, serves as a vital platform for advancing the field of pharmaceutical sciences. With an ISSN of 1567-2018 and an E-ISSN of 1875-5704, this esteemed journal focuses on all aspects of drug delivery systems, encompassing innovative research and developments that aim to improve therapeutics and patient outcomes. Operating from the United Arab Emirates, it has an impressive standing reflected in its 2023 Q2 ranking in Pharmaceutical Sciences and a notable position within the 62nd percentile in Scopus’s Pharmacology, Toxicology, and Pharmaceutics category. The journal not only acts as an essential resource for researchers and professionals but it also encourages the dissemination of knowledge among students and budding scientists. With the latest articles and reviews converging from 2004 to 2024, Current Drug Delivery remains committed to offering high-quality content that enhances understanding and sparks innovation in drug delivery mechanisms.

Nanotechnology Reviews

Connecting Ideas, Transforming Futures
Publisher: DE GRUYTER POLAND SP Z O OISSN: 2191-9089Frequency: 1 issue/year

Nanotechnology Reviews, published by DE GRUYTER POLAND SP Z O O, stands at the forefront of the multidisciplinary field of nanoscience and nanotechnology. With an Open Access model adopted since 2019, this journal, identifiable by its ISSN 2191-9089 and E-ISSN 2191-9097, disseminates vital research that is accessible to a global audience. The journal is located in Germany and has established itself as a premier platform for innovative research, boasting impressive quartile rankings: Q1 across several categories including Biotechnology, Energy Engineering, and Materials Science, as well as a Q2 classification in Biomaterials as of 2023. The diverse scope enables authors to contribute to a range of topics, from biomedical applications to energy solutions and advanced materials, making it essential reading for researchers, professionals, and students passionate about cutting-edge developments. Additionally, with Scopus rankings highlighting its value across various domains and robust percentiles, including 94 in Engineering (miscellaneous), 93 in Medicine (miscellaneous), and 88 in Biotechnology, Nanotechnology Reviews is an influential and respected journal that fosters scientific dialogue and innovation.

Advanced Therapeutics

Advancing the frontiers of medical innovation.
Publisher: WILEYISSN: Frequency: 12 issues/year

Advanced Therapeutics, published by WILEY in the United Kingdom, stands at the forefront of medical and pharmaceutical research, offering invaluable insights from 2018 to 2024. This distinguished journal, with an E-ISSN of 2366-3987, is recognized for its exceptional academic rigor, boasting an impressive array of Q1 categorizations in essential fields such as Biochemistry (medical), Pharmaceutical Science, and Pharmacology. With its strategic focus on interdisciplinary studies and cutting-edge therapeutic developments, Advanced Therapeutics serves as a vital resource for researchers, professionals, and students keen on advancing their knowledge and contributing to the evolving landscape of medicine and genetics. The journal's high Scopus rankings further affirm its impact, with significant placements in multiple categories underscoring the quality of published research. Although the journal operates under a subscription model, its accessibility to high-impact findings ensures that it remains a pivotal platform for innovative discourse in therapeutics.

BIOMATERIALS

Advancing the Future of Biomaterials Research
Publisher: ELSEVIER SCI LTDISSN: 0142-9612Frequency: 36 issues/year

BIOMATERIALS, published by Elsevier Science Ltd, is a premier academic journal dedicated to the interdisciplinary field of biomaterials research. With an impressive impact factor, it ranks in the Q1 quartile across multiple categories including Bioengineering, Biomaterials, and Biophysics, showcasing its significance in advancing scientific knowledge. Established in 1980 and set to converge its discussions through 2025, this journal provides a critical platform for researchers and professionals to disseminate their findings on the development, application, and performance of biomaterials. The journal covers a wide range of topics, from the mechanics of materials to nanotechnology, and is highly regarded with top Scopus rankings in essential categories, including an exceptional position within the 99th percentile for Biophysics. Although not an open access journal, BIOMATERIALS remains vital for students and established researchers alike, ensuring accessibility to groundbreaking research in the field. Engage with cutting-edge studies that pave the way for innovative applications in medicine, engineering, and beyond.

DRUG DELIVERY

Transforming Research into Revolutionary Drug Delivery
Publisher: TAYLOR & FRANCIS LTDISSN: 1071-7544Frequency: 1 issue/year

DRUG DELIVERY is a premier academic journal published by TAYLOR & FRANCIS LTD, with a steadfast commitment to advancing research in the fields of medicine and pharmaceutical sciences. As an Open Access journal since 2017, it offers unparalleled accessibility to its high-quality content, making it an invaluable resource for researchers, professionals, and students alike. With an impressive 2023 impact factor, it ranks in the Q1 quartile for both Medicine (miscellaneous) and Pharmaceutical Science, evidencing its significant impact within the scientific community. The journal focuses on innovative drug delivery systems, therapeutics, and methodologies that enhance patient care and treatment options. Based in the United Kingdom, it has evolved since its inception in 1993 to create a richly diverse platform for scholarly dialogue and advancements in the pharmaceutical landscape. Researchers looking to stay at the forefront of drug delivery research will find DRUG DELIVERY an essential companion in their pursuits.

ACS Nano

Driving Discovery in the World of Nanoscale Research
Publisher: AMER CHEMICAL SOCISSN: 1936-0851Frequency: 12 issues/year

ACS Nano, published by the American Chemical Society, stands as a prestigious journal in the domains of Engineering, Materials Science, Nanoscience, and Physics. With an exceptional impact factor reflecting its standing as a Q1 category journal in multiple disciplines, it plays a pivotal role in disseminating groundbreaking research from 2007 to 2024. Known for its rigorous peer-review process, the journal boasts impressive Scopus rankings—positioned at #1 in General Engineering and #6 in General Physics and Astronomy—placing it among the top 1% of journals in its field. Although it is not an open-access publication, ACS Nano provides a wealth of knowledge that is essential for advancing the development of nanotechnology and its applications across various industries. Researchers, professionals, and students alike will find in its pages a trove of innovative studies and insights that drive the future of materials science and engineering.

Biomaterials Research

Fostering collaboration in the world of biomaterials.
Publisher: AMER ASSOC ADVANCEMENT SCIENCEISSN: 1226-4601Frequency: 1 issue/year

Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.

Journal of Experimental Nanoscience

Catalyzing Discoveries in Nanoscience and Beyond
Publisher: TAYLOR & FRANCIS LTDISSN: 1745-8080Frequency: 1 issue/year

The Journal of Experimental Nanoscience, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing the field of nanoscience and its applications across various disciplines. Since its establishment, the journal has aimed to provide a comprehensive platform for researchers and professionals to disseminate innovative findings in nanotechnology, bioengineering, and materials science. With an ISSN of 1745-8080 and E-ISSN of 1745-8099, this journal has been pivotal in promoting high-quality research in its converged years from 2006 to 2024. Recognized for its contributions, it currently holds a Q3 ranking in core categories such as Bioengineering, Biomedical Engineering, Materials Science, and Nanoscience and Nanotechnology. Although its H-index is not specified, its Scopus ranks reflect its growing influence, with notable percentiles in various engineering fields. By offering open access since 2016, the Journal of Experimental Nanoscience enhances the accessibility of vital research to a global audience. Researchers, professionals, and students will find this journal an invaluable resource for staying abreast of the latest advancements and breakthroughs in nanoscience.

Advances in Nano Research

Innovating Tomorrow’s Technologies Today
Publisher: TECHNO-PRESSISSN: 2287-237XFrequency: 12 issues/year

Advances in Nano Research, published by TECHNO-PRESS, is a prominent academic journal dedicated to advancing knowledge across various facets of nanoscience and nanotechnology. With its ISSN of 2287-237X and E-ISSN 2287-2388, this journal serves as a vital resource for researchers and professionals, focusing on areas such as Atomic and Molecular Physics, Biotechnology, Catalysis, Ceramics and Composites, and Electrical Engineering. Since its inception in 2017, the journal has notably achieved Q2 ranking in multiple categories for the year 2023, reflecting its commitment to high-quality research dissemination and its increasing influence in Scopus rankings, including ranks within the top 12% in Chemical Engineering. While Open Access options are currently unavailable, the rigorous peer-review process ensures that only the most impactful studies are published, further solidifying its importance within the academic community. As a significant player in the fields of engineering and materials science, Advances in Nano Research aims to foster innovation and collaboration, making it an essential publication for those engaged in cutting-edge research and development within the realm of nanotechnology.

JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE

Shaping Medical Technologies with Advanced Materials Research
Publisher: SPRINGERISSN: 0957-4530Frequency: 1 issue/year

JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE is a leading peer-reviewed journal published by Springer, dedicated to advancing the field of biomedical materials science. With an ISSN of 0957-4530 and E-ISSN 1573-4838, this Open Access journal has been committed to providing researchers and professionals with freely accessible, high-quality research since 2021. It features an extensive scope spanning bioengineering, biomaterials, biomedical engineering, and biophysics, reflecting its significant impact within these interdisciplinary domains. Recognized within the Q2 category of the 2023 rankings in multiple fields, the journal proudly positions itself as a crucial resource for innovative materials that contribute to advancements in medical applications. With impressive Scopus rankings, including 26th in Biophysics and 40th in Materials Science for Biomaterials, researchers, students, and industry professionals alike can rely on this publication for cutting-edge insights that drive the future of medical materials and technologies. Based in Dordrecht, Netherlands, the journal provides a vibrant platform for sharing groundbreaking discoveries and fostering collaborative research among a global audience.